Shailesh Joshi, MD
Internal Medicine · Sebring, FLNPI 1023033040
Payments from drug & device makers
What this record shows
5 manufacturers reported payments, led by Sekisui Diagnostics LLC at 52.4% of the total. Reporting peaked in 2024 at $490 and has fallen 84.7% since, to $75 in 2025.
Across 19 payments — averaging $54.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sekisui Diagnostics LLC$540
- Mylan Specialty L.p.$209
- Harmony Biosciences LLC$172
- Vertos Medical, Inc.$98
- Medtronic$11
What the payments were for
- Food & beverage$49048%
- Gifts$54052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sekisui Diagnostics LLC | 3 | $540 |
| Mylan Specialty L.p. | 9 | $209 |
| Harmony Biosciences LLC | 5 | $172 |
| Vertos Medical, Inc. | 1 | $98 |
| Medtronic | 1 | $11 |
How this compares
$1,030 in reported general payments places this provider in the 70th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 28 | $40,176 |
| EliquisApixaban | 43 | $28,136 |
| XareltoRivaroxaban | 23 | $23,137 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $16,355 |
| JardianceEmpagliflozin | 17 | $14,320 |
| SymbicortBudesonide/Formoterol Fumarate | 35 | $10,843 |
| Famotidine | 56 | $5,120 |
| Atorvastatin Calcium | 271 | $3,587 |
| PaxlovidNirmatrelvir/Ritonavir | 14 | $2,760 |
| Gabapentin | 90 | $2,451 |
| Vancomycin Hcl | 21 | $1,952 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 98 | $1,928 |
| Rosuvastatin Calcium | 55 | $1,897 |
| Amlodipine Besylate | 249 | $1,876 |
| Fenofibrate | 67 | $1,801 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Sebring
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.